Peroxiredoxin III protects pancreatic β cells from apoptosis

Journal of Endocrinology

Volumn 207, Issue 2, 2010, Pages 163-175

  Wolf, Gabriele ^a   Aumann, Nicole ^a   Michalska, Marta ^a   Bast, Antje ^a   Sonnemann, Jürgen ^b   Beck, James F ^b   Lendeckel, Uwe ^a   Newsholme, Philip ^c   Walther, Reinhard ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; DOXYCYCLINE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PEROXIREDOXIN 3; STREPTOZOCIN;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL STRESS; CELL VIABILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINOMA; ISOLATED PANCREAS ISLET; MEMBRANE POTENTIAL; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CASPASE 3; CASPASE 9; CELL LINE; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HYDROGEN PEROXIDE; INSULIN-SECRETING CELLS; INSULINOMA; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE II; PANCREAS; PEROXIREDOXINS; RATS; STREPTOZOCIN;

EID: 78049391251     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0455     Document Type: Article

References (51)

1. Abdel-Rahman MS, Elrakhawy FI & Iskander FA 1992 Protection of B cells against the effect of alloxan. Toxicology Letters 63 155-164. (doi:10.1016/0378-4274(92)90007-7)
2. Adrain C & Martin SJ 2001 The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends in Biochemical Sciences 26 390-397. (doi:10.1016/S0968-0004(01)01844-8)
3. Araki M, Nanri H, Ejima K, Murasato Y, Fujiwara T, Nakashima Y & Ikeda M 1999 Antioxidant function of the mitochondrial protein SP-22 in the cardiovascular system. Journal of Biological Chemistry 274 2271-2278. (doi:10.1074/jbc.274.4.2271)
4. Azevedo-Martins AK, Lortz S, Lenzen S, Curi R, Eizirik DL & Tiedge M 2003 Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-κB activation in insulin-producing cells. Diabetes 52 93-101. (doi:10.2337/diabetes.52.1.93)
5. Bast A, Wolf G, Oberbäumer I & Walther R 2002 Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells. Diabetologia 45 867-876. (doi:10.1007/s00125-002-0846-1)
6. Bernabe JC, Tejedo JR, Rincon P, Cahuana GM, Ramirez R, Sobrino F & Bedoya F 2001 Sodium nitroprusside-induced mitochondrial apoptotic events in insulin-secreting RINm5F cells are associated with MAP kinases activation. Experimental Cell Research 269 222-229. (doi:10.1006/excr.2001.5315)
7. Chae HZ, Kim HJ, Kang SW & Rhee SG 1999 Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin. Diabetes Research and Clinical Practice 45 101-112. (doi:10.1016/S0168-8227(99)00037-6)
8. Chang TS, Cho CS, Park S, Yu S, Kang SW & Rhee SG 2004 Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. Journal of Biological Chemistry 279 41975-41984. (doi:10.1074/jbc.M407707200)
9. 2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell 7 866-878. (doi:10.1111/j.1474-9726.2008.00432.x)
10. Chua PJ, Lee EH, Yu Y, Yip GW, Tan PH & Bay BH 2010 Silencing the peroxiredoxin III gene inhibits cell proliferation in breast cancer. International Journal of Oncology 36 359-364. (doi:10.3892/ijo-00000507)
11. Delaney CA, Paviovic D, Hoorens A, Pipeleers DG & Eizirik DL 1997 Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138 2610-2614. (doi:10.1210/en.138.6.2610)
12. Eizirik DL & Mandrup-Poulsen T 2001 A choice of death - the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44 2115-2133. (doi:10.1007/s001250100021)
13. Gandy SE, Buse MG & Crouch RK 1982 Protective role of superoxide dismutase against diabetogenic drugs. Journal of Clinical Investigation 70 650-658. (doi:10.1172/JCI110659)
14. Grankvist K, Marklund SL & Täljedal IB 1981 CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochemical Journal 199 393-398.
15. Gurgul E, Lortz S, Tiedge M, Jörns A & Lenzen S 2004 Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines. Diabetes 53 2271-2280. (doi:10.2337/diabetes.53.9.2271)
16. Harmon JS, Bogdani M, Parazzoli SD, Mak SS, Oseid EA, Berghmans M, Leboeuf RC & Robertson RP 2009 β-Cell-specific overexpression of glutathione peroxidase preserves intranuclear MafA and reverses diabetes in db/db mice. Endocrinology 150 4855-4862. (doi:10.1210/en.2009-0708)
17. Hattori F, Murayama N, Noshita T & Oikawa S 2003 Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo. Journal of Neurochemistry 86 860-868. (doi:10.1046/j.1471-4159.2003.01918.x)
18. Hotta M, Tashiro F, Ikegami H, Niwa H, Ogihara T, Yodoi J & Miyazaki J 1998 Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes. Journal of Experimental Medicine 188 1445-1451. (doi:10.1084/jem.188. 8.1445)
19. Kang SW, Rhee SG, Chang TS, Jeong W & Choi MH 2005 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications. Trends in Molecular Medicine 11 571-578. (doi:10.1016/j.molmed. 2005.10.006)
20. Kiely A, McClenaghan NH, Flatt PF & Newsholme P 2007 Pro-inflammatory cytokines increase glucose, alanine and triacylglycerol utilization but inhibit insulin secretion in a clonal pancreatic beta-cell line. Journal of Endocrinology 195 113-123. (doi:10.1677/JOE-07-0306)
21. Knopp E, Arndt TL, Eng KL, Caldwell M, LeBoeuf RC, Deeb SS & O'Brien KD 1999 Murine phospholipid hydroperoxide glutathione peroxidase: cDNA sequence, tissue expression, and mapping. Mammalian Genome 10 601-605. (doi:10.1007/s003359901053)
22. L'Abbe MR & Trick KD 1994 Changes in pancreatic glutathione peroxidase and superoxide dismutase activities in the prediabetic diabetes-prone BB rat. Proceedings of the Society for Experimental Biology and Medicine 207 206-121.
23. 2-specific induction of PRDX3 in the eye lens. Molecular Vision 13 1469-1474.
24. Lenzen S, Drinkgern J & Tiedge M 1996 Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radical Biology and Medicine 20 463-466. (doi:10.1016/0891-5849(96)02051-5)
25. Li X, Chen H & Epstein PN 2006 Metallothionein and catalase sensitize to diabetes in nonobese diabetic mice: reactive oxygen species may have a protective role in pancreatic beta-cells. Diabetes 55 1592-1604. (doi:10.2337/db05-1357)
26. Lottmann H, Vanselow J, Hessabi B & Walther R 2001 The Tet-On system in transgenic mice: inhibition of the mouse pdx-1 gene activity by antisense RNA expression in pancreatic beta-cells. Journal of Molecular Medicine 79 321-328. (doi:10.1007/s001090100229)
27. Maechler P, Kennedy ED, Pozzan T & Wollheim CB 1997 Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic beta-cells. EMBO Journal 16 3833-3841. (doi:10.1093/emboj/16.13.3833)
28. Mandrup-Poulsen T, Helqvist S, Wogensen LD, Molvig J, Pociot F, Johannesen J & Nerup J 1990 Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. Current Topics in Microbiology and Immunology 164 169-193.
29. Masaki M, Ikeda A, Shiraki E, Oka S & Kawasaki T 2003 Mixed lineage kinase LZK and antioxidant protein-1 activate NF-κB synergistically. European Journal of Biochemistry 270 76-83. (doi:10.1046/j.1432-1033.2003.03363. x)
30. Maxwell SR, Thomason H, Sandler D, Leguen C, Baxter MA, Thorpe GH, Jones AF & Barnett AH 1997 Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. European Journal of Clinical Investigation 27 484-490. (doi:10.1046/j.1365-2362.1997.1390687.x)
31. McDaniel ML, Kwon G, Hill JR, Marshall CA & Corbett JA 1996 Cytokines and nitric oxide in islet inflammation and diabetes. Proceedings of the Society for Experimental Biology and Medicine 211 24-32.
32. 2-induced mouse islet or clonal pancreatic beta cell dysfunction. Bioscience Reports 30 445-453. (doi:10.1042/BSR20090138)
33. Miranda-Vizuete A, Damdimopoulos AE & Spyrou G 2000 The mitochondrial thioredoxin system. Antioxidants & Redox Signaling 2 801-810. (doi:10.1089/ars.2000.2.4-801)
34. Mitsumoto A, Takanezawa Y, Okawa K, Iwamatsu A & Nakagawa Y 2001 Variants of peroxiredoxins expression in response to hydroperoxide stress. Free Radical Biology and Medicine 30 625-635. (doi:10.1016/S0891-5849(00)00503-7)
35. Nargi-Aizenman JL, Simbulan-Rosenthal CM, Kelly TA, Smulson ME & Griffin DE 2002 Rapid activation of poly(ADP-ribose) polymerase contributes to Sindbis virus and staurosporine-induced apoptotic cell death. Virology 293 164-171. (doi:10.1006/viro.2001.1253)
36. Nonn L, Berggren M & Powis G 2003 Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Molecular Cancer Research 1 682-689.
37. Petrosillo G, Ruggiero FM & Paradies G 2003 Role of reactive oxygen species and cardiolipin in the release of cytochrome c from mitochondria. FASEB Journal 17 2202-2208. (doi:10.1096/fj.03-0012com)
38. Pi J, Bai Y, Zhang Q, Wong V, Floering LM, Daniel K, Reece JM, Deeney JT, Andersen ME, Corkey BE et al. 2007 Reactive oxygen species as a signal in glucose-stimulated insulin secretion. Diabetes 56 1783-1791. (doi:10.2337/db06-1601)
39. Rabinovitch A & Suarez-Pinzon WL 1998 Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochemical Pharmacology 55 1139-1149. (doi:10.1016/S0006-2952(97)00492-9)
40. Rabinovitch A, Suarez-Pinzon W, Strynadka K, Ju Q, Edelstein D, Brownlee M, Korbutt GS & Rajotte RV 1999 Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes 48 1223-1229. (doi:10.2337/diabetes.48.6.1223)
41. Radi R, Turrens JF, Chang LY, Bush KM, Crapo JD & Freeman BA 1991 Detection of catalase in rat heart mitochondria. Journal of Biological Chemistry 266 22028-22034.
42. Sandstrom J, Jonsson LM, Edlund H, Holmberg D & Marklund SL 2002 Overexpression of extracellular-SOD in islets of nonobese diabetic mice and development of diabetes. Free Radical Biology and Medicine 33 71-75. (doi:10.1016/S0891-5849(02)00859-6)
43. Storling J, Binzer J, Andersson AK, Zullig RA, Tonnesen M, Lehmann R, Spinas GA, Sandler S, Billestrup N & Mandrup-Poulsen T 2005 Nitric oxide contributes to cytokine-induced apoptosis in pancreatic beta cells via potentiation of JNK activity and inhibition of Akt. Diabetologia 48 2039-2050. (doi:10.1007/s00125-005-1912-2)
44. Suarez-Pinzon WL, Mabley JG, Strynadka K, Power RF, Szabo C & Rabinovitch A 2001 An inhibitor of inducible nitric oxide synthase and scavenger of peroxynitrite prevents diabetes development in NOD mice. Journal of Autoimmunity 16 449-455. (doi:10.1006/jaut.2001.0507)
45. Tanaka T, Hosoi F, Yamaguchi-Iwai Y, Nakamura H, Masutani H, Ueda S, Nishiyama A, Takeda S, Wada H, Spyrou G et al. 2002 Thioredoxin-2 (TRX-2) is an essential gene regulating mitochondria-dependent apoptosis. EMBO Journal 21 1695-1703. (doi:10.1093/emboj/21.7.1695)
46. Tiedge M, Lortz S, Drinkgern J & Lenzen S 1997 Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46 1733-1742. (doi:10.2337/diabetes.46.11. 1733)
47. Verge CF, Gianani R, Yu L, Pietropaolo M, Smith T, Jackson RA, Soeldner JS & Eisenbarth GS 1995 Late progression to diabetes and evidence for chronic beta-cell autoimmunity in identical twins of patients with type I diabetes. Diabetes 44 1176-1179. (doi:10.2337/diabetes.44.10.1176)
48. Watabe S, Hiroi T, Yamamoto Y, Fujioka Y, Hasegawa H, Yago N & Takahashi SY 1997 SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. European Journal of Biochemistry 249 52-60. (doi:10.1111/j.1432- 1033.1997.t01-1-00052.x)
49. Wonsey DR, Zeller KI & Dang CV 2002 The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation. PNAS 99 6649-6654. (doi:10.1073/pnas.102523299)
50. Wood ZA, Schroder E, Robin Harris J & Poole LB 2003 Structure, mechanism and regulation of peroxiredoxins. Trends in Biochemical Sciences 28 32-40. (doi:10.1016/S0968-0004(02)00003-8)
51. Yamamoto T, Matsui Y, Natori S & Obinata M 1989 Cloning of a housekeeping-type gene (MER5) preferentially expressed in murine erythroleukemia cells. Gene 80 337-343. (doi:10.1016/0378-1119(89)90297-7)